Editorspicks
Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds
DENVER, July 21, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group™ (NEO: MYCO)(OTC:MYCOF)(FSE: 0NFA)(“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for ... [Read]
Editorspicks
Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Mydecine Innovations Group™(CSE:MYCO)(OTC:MYCOF)(FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, ... [Read]